Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Combotope Therapeutics ApS
APS
Active
Advertising protection
CVR 44308266
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 2 years old
4 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Combotope Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-1M
-2M
-2M
-2M
2024
-1M
+50%
2025
EBITDA
DKK millions
0M
-1M
-2M
-3M
-4M
-3M
2024
-1M
+67%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
-2.060
-633
Staff expenses
-734
-549
EBITDA
-2.793
-1.182
Depreciation & amort.
-9
-16
EBIT
-2.803
-1.198
Net financials
1
0
Profit before tax
-2.801
-1.198
Tax
-616
-263
Net profit
-2.185
-934
Balance sheet
DKK thousands
Item
2024
2025
Total assets
1.381
1.089
Equity
1.355
1.070
Long-term debt
0
0
Short-term debt
26
19
Total debt
26
19
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-118207100.0%
This company
2024
2025
Equity ratio
98.3%
This company
38.2%
Market median
157% above market
2024
2025
Return on equity
-87.3%
This company
18.4%
Market median
574% below market
2024
2025
Net profit margin (of gross profit)
-93439400.0%
This company
2024
2025
Asset turnover (of gross profit)
-0.58×
This company
2024
2025
Debt / equity
0.02×
This company
0.62×
Market median
97% below market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-09-14 – 2024-12-31
View
PDF
More on Combotope Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
